Transfusion transmitted infections in armed forces: Prevalence and trends

Medical Journal Armed Forces India

Volumn 62, Issue 4, 2006, Pages 348-350

  Gupta, P K ^a   Kumar, H ^a   Basannar, D R ^a   Jaiprakash, M ^b  

^a ARMED FORCES MEDICAL COLLEGE   (India)

^b DGAFMS   (India)

Author keywords

Hepatitis B virus; Hepatitis C virus; Human immunodeficiency virus; Transfusion transmitted infections

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN;

ARMY; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INDIA; MAJOR CLINICAL STUDY; NUCLEIC ACID AMPLIFICATION; POSTTRANSFUSION HEPATITIS; PREVALENCE; RISK REDUCTION; SENSITIVITY ANALYSIS; SEXUALLY TRANSMITTED DISEASE; TORQUE TENO VIRUS; TREND STUDY; VENEREAL DISEASE REACTION TEST;

EID: 33750309139     PISSN: 03771237     EISSN: 03771237     Source Type: Journal    
DOI: 10.1016/S0377-1237(06)80105-X     Document Type: Article

References (16)

1. Glynn SA, Kleinman SH, Wright DJ, Busch MP. International application of the incidence rate and window-period model (editorial). National Heart, Lung and Blood Institute Retrovirus Epidemiology Donor Study. Transfusion 2002;42:966-73.
2. Dodd RY, Notari EP, Stamer SL. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross Blood Donor population. Transfusion 2002; 42:975-9.
3. Klein HG. Will blood Transfusion ever be safe enough? JAMA 2000;284:238-40.
4. Busch MP, Kleinman SH, Stramer SL. Nucleic acid amplification testing of blood donations. In: Sibinger S, Klein HG editors. Molecular biology in blood transfusion. 1st ed.Netherlands: Kluwer Academic Publications, 2000; 81-103.
5. Fiebig EW, Busch MP. Emerging infections in transfusion medicine. Clin Lab Med 2004;24:797-823.
6. Alvarez M, Oyonarte S, Rodriguez PM, Hernandez JM. Estimated risk of transfusion-transmitted viral infections in Spain. Transfusion 2002; 42:994-8.
7. Busch MP, Glynn SA, Stramer SL, Strong DM, Caglioti S, Wright DJ, et al. NHLBIREDS NAT study group: A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005; 45:254-64.
8. Pomper GJ, Wu Y, Synder EL. Risks of transfusion-transmitted infections. Curr Opin Hematol 2003;10:412-8.
9. Glynn SA, Kleinman SH, Wright DJ, Busch MP. For the NHLBI Retrovirus Epidemiology Donor study: International application of the incidence rate/window period model. Transfusion 2002;42: 966-72.
10. Makroo RN, Salil P, Vashist RP, Lal S. Trends of HIV infection in blood donors of Delhi. Indian J Pathol Microbiol 1996; 39: 139-42.
11. Choudhury N, Phadke S. Transfusion transmitted diseases. Indian J Pediat 2001;68:951-8.
12. Nanu A, Sharma SP, Chatterjee K, Jyoti P. Markers for transfusion transmissible infections in north Indian voluntary and replacement donors: prevalence and trends 1989 to 1999. Vox Sang 1997;73:70-3.
13. Ghuman HK. Detection of Hepatitis C virus by third generation enzyme immunoassay. Indian J Gastroenterol 1995; 14:154.
14. Makroo RN, Raina V, Kaushik V. Prevalence of Hepatitis C virus antibody in healthy blood donors. Indian J Med Res 1999; 10: 13-5.
15. Singh B, Kataria SP, Gupta R. Infectious markers in blood donors of East Delhi: Prevalence and trends. Indian J Pathol Microbiol 2004; 47: 477-9.
16. Jackson BR, Busch MP. Stramer SL, AuBuchon JP. The cost - effectiveness of NAT for HIV, HCV, and HBV in whole - blood donations. Transfusion 2003; 43: 721-9.